Developmental cardiac hypertrophy in a mouse model of prolidase deficiency

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 4, 2011, Pages 204-217

  Jung, Seungwoo ^a,e   Silvius, Derek ^b   Nolan, Katherine A ^a   Borchert, Gregory L ^c   Millet, Yoann H ^a   Phang, James M ^d   Gunn, Teresa M ^a,b  

^a Cornell University ^*  (United States)

^b MCLAUGHLIN RESEARCH INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac hypertrophy; Collagen; peptidase d (Pepd); Pigmentation; Prolidase deficiency

Indexed keywords

BROXURIDINE; COLLAGEN; PROLINE DIPEPTIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE MUTATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; LOSS OF FUNCTION MUTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLIDASE DEFICIENCY; ZEBRA FISH;

ANIMALS; CARDIOMEGALY; CELL SIZE; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HEART; MICE; MICE, INBRED C3H; MICE, INBRED CBA; MUTATION; MYOCYTES, CARDIAC; PHENOTYPE; PROLIDASE DEFICIENCY; PROLINE; ZEBRAFISH;

DANIO RERIO; MUS;

EID: 79954500910     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20789     Document Type: Article

References (55)

1. Alcalai R, Seidman JG, Seidman CE. 2008. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 19: 104-110.
2. Anversa P, Olivetti G, Bracchi PG, Loud AV. 1981. Postnatal development of the M-band in rat cardiac myofibrils. Circ Res 48: 561-568.
3. Besio R, Alleva S, Forlino A, et al. 2010. Identifying the structure of the active sites of human recombinant prolidase. Eur Biophys J 39: 935-945.
4. Chung MW, Tsoutsman T, Semsarian C. 2003. Hypertrophic cardiomyopathy: from gene defect to clinical disease. Cell Res 13: 9-20.
5. Cota CD, Liu RR, Sumberac TM, et al. 2008. Genetic and phenotypic studies of the dark-like mutant mouse. Genesis 46: 562-573.
6. Dlugosz AA, Antin PB, Nachmias VT, Holtzer H. 1984. The relationship between stress fiber-like structures and nascent myofibrils in cultured cardiac myocytes. J Cell Biol 99: 2268-2278.
7. Dorn GW2nd, Force T. 2005. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115: 527-537.
8. Endo F, Matsuda I. 1991. Molecular basis of prolidase (peptidase D) deficiency. Mol Biol Med 8: 117-127.
9. Falik-Zaccai TC, Khayat M, Luder A, et al. 2010. A broad spectrum of developmental delay in a large cohort of prolidase deficiency patients demonstrates marked interfamilial and intrafamilial phenotypic variability. Am J Med Genet B Neuropsychiatr Genet 153B: 46-56.
10. Harris B, Ward-Bailey P, Johnson K, et al. 2003. A new recessive color mutation on mouse chromosome 7, dark-like. Mouse mutant resources web site, The Jackson Laboratory, Bar Harbor, Maine (), MGI Direct Data Submission 2003.
11. Holt MR, Koffer A. 2001. Cell motility: proline-rich proteins promote protrusions. Trends Cell Biol 11: 38-46.
12. Horio T, Nishikimi T, Yoshihara F, et al. 2000. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35(1 Pt 1): 19-24.
13. Hughes SE, McKenna WJ. 2005. New insights into the pathology of inherited cardiomyopathy. Heart 91: 257-264.
14. Ieda M, Tsuchihashi T, Ivey KN, et al. 2009. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 16: 233-244.
15. Jackson SH, Dennis AW, Greenberg M. 1975. Iminodipeptiduria: a genetic defect in recycling collagen; a method for determining prolidase in erythrocytes. Can Med Assoc J 113: 759, 762-763.
16. Jones TR, Kang IH, Wheeler DB, et al. 2008. CellProfiler Analyst: data exploration and analysis software for complex image-based screens. BMC Bioinformatics 9: 482.
17. Keller RS, Shai SY, Babbitt CJ, et al. 2001. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am J Pathol 158: 1079-1090.
18. Lal H, Verma SK, Foster DM, et al. 2009. Integrins and proximal signaling mechanisms in cardiovascular disease. Front Biosci 14: 2307-2334.
19. Li F, Wang X, Capasso JM, Gerdes AM. 1996. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746.
20. Liu Y, Borchert GL, Donald SP, et al. 2009. Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res 69: 6414-6422.
21. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Lupi A, Rossi A, Campari E, et al. 2006. Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. J Med Genet 43: e58.
23. Lupi A, Tenni R, Rossi A, et al. 2008. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. Amino Acids 35: 739-752.
24. Marian AJ. 2008. Genetic determinants of cardiac hypertrophy. Curr Opin Cardiol 23: 199-205.
25. Maron BJ, Gardin JM, Flack JM, et al. 1996. HCM in the general population. Circulation 94: 588-589.
26. Maron BJ, Gardin JM, Flack JM, et al. 1995. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92: 785-789.
27. Mori AD, Bruneau BG. 2004. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 19: 211-215.
28. Myara I, Charpentier C, Lemonnier A, et al. 1982. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta 125: 193-205.
29. Myara I, Charpentier C, Lemonnier A, et al. 1984. Prolidase and prolidase deficiency. Life Sci 34: 1985-1998.
30. Olivetti G, Anversa P, Loud AV. 1980. Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res 46: 503-512.
31. Palka JA, Phang JM. 1997. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 67: 166-175.
32. Pall GS, Wallis J, Axton R, et al. 2004. A novel transmembrane MSP-containing protein that plays a role in right ventricle development. Genomics 84: 1051-1059.
33. Peng X, Kraus MS, Wei H, et al. 2006. Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest 116: 217-227.
34. Peng X, Wu X, Druso JE, et al. 2008. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci U S A 105: 6638-6643.
35. Pham CG, Harpf AE, Keller RS, et al. 2000. Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol Heart Circ Physiol 279: H2916-2926.
36. Phang JM, Pandhare J, Liu Y. 2008. The metabolism of proline as microenvironmental stress substrate. J Nutr 138: 2008S-2015S.
37. Rajagopal SK, Ma Q, Obler D, et al. 2007. Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 43: 677-685.
38. Ren J, Avery J, Zhao H, et al. 2007. Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation. J Mol Cell Cardiol 42: 367-377.
39. Richardson J, Lundegaard PR, Reynolds NL, et al. 2008. mc1r Pathway regulation of zebrafish melanosome dispersion. Zebrafish 5: 289-295.
40. Rigor DL, Bodyak N, Bae S, et al. 2009. Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function. Am J Physiol Heart Circ Physiol 296: H566-572.
41. Ross RS, Pham C, Shai SY, et al. 1998. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res 82: 1160-1172.
42. Sakata Y, Kamei CN, Nakagami H, et al. 2002. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A 99: 16197-16202.
43. Shioi T, Kang PM, Douglas PS, et al. 2000. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. Embo J 19: 2537-2548.
44. Shioi T, McMullen JR, Kang PM, et al. 2002. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 22: 2799-2809.
45. Soonpaa MH, Kim KK, Pajak L, et al. 1996. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271(5 Pt 2): H2183-2189.
46. Sprague J, Doerry E, Douglas S, Westerfield M. 2001. The Zebrafish Information Network (ZFIN): a resource for genetic, genomic and developmental research. Nucleic Acids Res 29: 87-90.
47. Surazyński A, Miltyk W, Palka J, Phang JM. 2008. Prolidase-dependent regulation of collagen biosynthesis. Amino Acids 35: 731-738.
48. Surazyński A, Palka J. 2001. FAK-independent regulation of prolidase activity and collagen biosynthesis in MCF-7 cells. Folia Histochem Cytobiol 39 Suppl 2: 212-213.
49. Surazyński A, Pałka J, Wołczyński S. 2001. Phosphorylation of prolidase increases the enzyme activity. Mol Cell Biochem 220: 95-101.
50. Tallini YN, Ohkura M, Choi BR, et al. 2006. Imaging cellular signals in the heart in vivo: cardiac expression of the high-signal Ca2+ indicator GCaMP2. Proc Natl Acad Sci U S A 103: 4753-4758.
51. Terai M, Komiyama M, Shimada Y. 1989. Myofibril assembly is linked with vinculin, alpha-actinin, and cell-substrate contacts in embryonic cardiac myocytes in vitro. Cell Motil Cytoskeleton 12: 185-194.
52. Terracio L, Rubin K, Gullberg D, et al. 1991. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res 68: 734-744.
53. Winston JB, Erlich JM, Green CA, et al. 2010. Heterogeneity of genetic modifiers ensures normal cardiac development. Circulation 121: 1313-1321.
54. Yap LB, Mukerjee D, Timms PM, et al. 2004. Natriuretic peptides, respiratory disease, and the right heart. Chest 126: 1330-1336.
55. Yarmola EG, Bubb MR. 2009. How depolymerization can promote polymerization: the case of actin and profilin. Bioessays 31: 1150-1160.